Why vaccines are a good investment

Why vaccines are a good investment An economist says lower health care costs are just the tip of the icebergBy Melinda Wenner David Bloom ARTICLE EXTRASThe Vaccine Conundrum David Bloom first became interested in international health in the late 1980s. At that time he was an established labor economist, and the economic aspects of the AIDS epid

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

An economist says lower health care costs are just the tip of the iceberg
By Melinda Wenner

David Bloom

ARTICLE EXTRAS

David Bloom first became interested in international health in the late 1980s. At that time he was an established labor economist, and the economic aspects of the AIDS epidemic intrigued him. Bloom recalls that his colleagues strongly discouraged him, telling him that "AIDS was a fad" and that "good scientists didn't work on trendy topics." He ignored them.

"Those kinds of comments had the unintended consequence of hastening my professional transition from US labor issues to global health," says Bloom, chair of the population and international health department at Harvard's School of Public Health. "And for the past 10 to 15 years, that's where I've concentrated my attention."

Bloom is perhaps best known for his 2005 study published in World Economics, with fellow Harvard economist David Canning and independent policy ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Melinda Wenner

    This person does not yet have a bio.

Published In

Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development